Gamble Jones Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $4.9M | Sell |
68,103
-25
| -0% | -$1.89K | 0.37% | 55 |
|
|
2022
Q3 | $4.84M | Sell |
68,128
-3,000
| -4% | -$218K | 0.39% | 51 |
|
|
2022
Q2 | $5.48M | Sell |
71,128
-9,360
| -12% | -$713K | 0.4% | 49 |
|
|
2022
Q1 | $5.88M | Sell |
80,488
-225
| -0.3% | -$15.1K | 0.37% | 53 |
|
|
2021
Q4 | $5.03M | Sell |
80,713
-3,582
| -4% | -$210K | 0.3% | 65 |
|
|
2021
Q3 | $4.99M | Sell |
84,295
-50
| -0.1% | -$3.29K | 0.33% | 62 |
|
|
2021
Q2 | $5.64M | Buy |
84,345
+50
| +0.1% | +$3.26K | 0.37% | 61 |
|
|
2021
Q1 | $5.32M | Sell |
84,295
-425
| -0.5% | -$26.4K | 0.36% | 62 |
|
|
2020
Q4 | $5.25M | Sell |
84,720
-9,177
| -10% | -$564K | 0.36% | 57 |
|
|
2020
Q3 | $5.66M | Sell |
93,897
-906
| -1% | -$54.5K | 0.41% | 50 |
|
|
2020
Q2 | $5.57M | Sell |
94,803
-220
| -0.2% | -$13.2K | 0.45% | 48 |
|
|
2020
Q1 | $5.3M | Sell |
95,023
-2,639
| -3% | -$161K | 0.49% | 44 |
|
|
2019
Q4 | $6.27M | Sell |
97,662
-1,146
| -1% | -$65.6K | 0.49% | 45 |
|
|
2019
Q3 | $5.01M | Sell |
98,808
-2,410
| -2% | -$113K | 0.41% | 51 |
|
|
2019
Q2 | $4.59M | Sell |
101,218
-1,306
| -1% | -$60.8K | 0.39% | 52 |
|
|
2019
Q1 | $4.89M | Sell |
102,524
-2,000
| -2% | -$99.6K | 0.43% | 51 |
|
|
2018
Q4 | $5.43M | Sell |
104,524
-1,923
| -2% | -$103K | 0.55% | 45 |
|
|
2018
Q3 | $6.61M | Sell |
106,447
-335
| -0.3% | -$19.9K | 0.61% | 40 |
|
|
2018
Q2 | $5.91M | Sell |
106,782
-1,250
| -1% | -$67.5K | 0.59% | 40 |
|
|
2018
Q1 | $6.83M | Sell |
108,032
-715
| -0.7% | -$46K | 0.68% | 32 |
|
|
2017
Q4 | $6.66M | Sell |
108,747
-1,999
| -2% | -$125K | 0.63% | 34 |
|
|
2017
Q3 | $7.06M | Sell |
110,746
-2,095
| -2% | -$122K | 0.72% | 31 |
|
|
2017
Q2 | $6.29M | Sell |
112,841
-624
| -0.5% | -$34K | 0.66% | 34 |
|
|
2017
Q1 | $6.17M | Sell |
113,465
-6,955
| -6% | -$381K | 0.65% | 34 |
|
|
2016
Q4 | $7.04M | Sell |
120,420
-702
| -0.6% | -$38.4K | 0.78% | 28 |
|
|
2016
Q3 | $6.53M | Sell |
121,122
-2,416
| -2% | -$155K | 0.71% | 31 |
|
|
2016
Q2 | $9.09M | Sell |
123,538
-1,700
| -1% | -$120K | 0.99% | 20 |
|
|
2016
Q1 | $8M | Sell |
125,238
-816
| -0.6% | -$51.5K | 0.89% | 26 |
|
|
2015
Q4 | $8.67M | Sell |
126,054
-3,407
| -3% | -$225K | 0.96% | 24 |
|
|
2015
Q3 | $7.66M | Sell |
129,461
-14,938
| -10% | -$948K | 0.88% | 25 |
|
|
2015
Q2 | $9.61M | Buy |
144,399
+275
| +0.2% | +$18.1K | 1% | 18 |
|
|
2015
Q1 | $9.3M | Buy |
144,124
+1
| +0% | +$63 | 0.97% | 21 |
|
|
2014
Q4 | $8.51M | Sell |
144,123
-650
| -0.4% | -$36.7K | 0.88% | 23 |
|
|
2014
Q3 | $7.41M | Sell |
144,773
-1,140
| -0.8% | -$56.9K | 0.82% | 26 |
|
|
2014
Q2 | $7.08M | Sell |
145,913
-2,224
| -2% | -$110K | 0.79% | 30 |
|
|
2014
Q1 | $7.7M | Sell |
148,137
-1,684
| -1% | -$89.6K | 0.89% | 23 |
|
|
2013
Q4 | $7.96M | Sell |
149,821
-2,728
| -2% | -$139K | 0.94% | 22 |
|
|
2013
Q3 | $7.06M | Sell |
152,549
-4,399
| -3% | -$193K | 0.91% | 22 |
|
|
2013
Q2 | $7.01M | Buy |
+156,948
| New | +$6.81M | 0.93% | 20 |
|
Other funds holding BMY
AWA
Gamble Jones Investment Counsel's BMY Position: Q4 2022 in Review
Gamble Jones Investment Counsel reduced its Bristol-Myers Squibb (BMY) stake by 0.04% in Q4 2022, selling an estimated $1.89K and leaving 68,103 shares worth $4.9M. The position accounts for 0.37% of the portfolio, ranked #55.
Gamble Jones Investment Counsel first reported a position in BMY in Q2 2013 and has held it in 39 quarters since. The position peaked at $9.61M in Q2 2015. 2,601 funds tracked by Wall St. Rank hold BMY as of Q4 2022.
- Gamble Jones Investment Counsel held 68,103 shares of Bristol-Myers Squibb worth $4.9M as of Q4 2022.
- Gamble Jones Investment Counsel sold 25 Bristol-Myers Squibb shares in Q4 2022, an estimated $1.89K.
- Bristol-Myers Squibb made up 0.37% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #55 holding.
- Gamble Jones Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 39 quarters since.
- Gamble Jones Investment Counsel's Bristol-Myers Squibb position peaked at $9.61M in Q2 2015.
- 2,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.
Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.